Exact Mass: 405.3031484
Exact Mass Matches: 405.3031484
Found 149 metabolites which its exact mass value is equals to given mass value 405.3031484,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cassaine
C24H39NO4 (405.28789340000003)
A tricyclic diterpenoid isolated from several plant species of the genus Erythrophleum.
Astromicin
C17H35N5O6 (405.25872100000004)
An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at position 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is administered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
N-Arachidonoyl Threonine
C24H39NO4 (405.28789340000003)
N-arachidonoyl threonine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Threonine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Threonine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Threonine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Astromicin
C17H35N5O6 (405.25872100000004)
Diterpene alkaloid
C24H39NO4 (405.28789340000003)
Minaxolone
N-(4-Methoxyphenyl)-all-trans-retinamide
N-[(S)-1-Phenylethyl]-labda-7,12(E),14-triene-17-amide
22alpha,23alpha-epoxy-10-epi-solanida-1,4,9-trien-3-one
(2E,4E,14E)-13-hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one
C28H39NO_2-Naphthalenol, decahydro-5-(1H-indol-3-ylmethyl)-1,4a-dimethyl-6-methylene-1-(4-methyl-3-penten-1-yl)-, (1S,2S,4aR,5R,8aR)
(±)N-(2-fluro-ethyl)-2,16-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
(±)N-(2-fluro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
(±)N-(2-fluro-ethyl)-2-methyl-5Z,8Z,11Z,14Z-tricosatetraenoyl amine
NAG-3H-ABA
C24H39NO4 (405.28789340000003)
(+/-)N-(2-fluro-ethyl)-2,16-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
(+/-)N-(2-fluro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
(+/-)-2-methyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine
12-HETE-GABA
C24H39NO4 (405.28789340000003)
15-HETE-GABA
C24H39NO4 (405.28789340000003)
12-oxo-PDA-Ile
C24H39NO4 (405.28789340000003)
(+/-)-2,16,-dimethyl-5,8,11,14-all-cis-docosatetraenoyl-2-fluoroethylamine
(+/-)N-(2-fluoro-ethyl)-2,17-dimethyl-5Z,8Z,11Z,14Z-docosatetraenoyl amine
(+/-)-2-methyl-5,8,11,14-all-cis-tricosatetraenoyl-2-fluoroethylamine
NA 24:5;O3
C24H39NO4 (405.28789340000003)
1-[(2S,3S,5S,8S,9S,10S,11R,13S,14S,17S)-11-(dimethylamino)-2-ethoxy-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
N-(4-Methoxyphenyl)-all-trans-retinamide
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
3-Hydroxy-4-(icosa-5,8,11,14-tetraenoylamino)butanoic acid
C24H39NO4 (405.28789340000003)
2-[trans-(4-Aminocyclohexyl)amino]-6-(benzyl-amino)-9-cyclopentylpurine
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
C21H35N5O3 (405.27397600000006)
3alpha,7alpha-Dihydroxy-12-oxo-5beta-cholanate
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
7alpha,12alpha-Dihydroxy-3-oxo-5beta-cholan-24-Oate
A bile acid anion that is the conjugate base of 7alpha,12alpha-dihydroxy-3-oxo-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
N-[[4-(diethylamino)phenyl]methyl]-1-[2-(1-piperidinyl)ethyl]-2-benzimidazolamine
22alpha,23alpha-Epoxy-solanida-1,4,9-trien-3-one
A natural product found in Solanum campaniforme.
N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4R,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4R,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C22H35N3O4 (405.26274300000006)
(2E,4E,14E)-13-Hydroperoxy-1-piperidin-1-ylicosa-2,4,14-trien-1-one
(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxynon-4-en-2-yl]hexadeca-7,10,13-trienamide
(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxynonan-2-yl)hexadeca-4,7,10,13-tetraenamide
(E)-2-(decanoylamino)-3-hydroxydec-4-ene-1-sulfonic acid
C20H39NO5S (405.25488040000005)
SPHP(21:1)
C21H44NO4P (405.30077940000007)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
SPHP(20:2)
C20H40NO5P (405.2643960000001)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C24H39NO4 (405.28789340000003)
(1s,2s,4ar,5s,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(4s,6s,8s,10s,11e,13e,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
(2e,5z,8s,10s,12s,14s)-8,10,12,14-tetramethoxy-2,5-dimethyl-7-methylideneheptadeca-2,5,16-trienenitrile
C24H39NO4 (405.28789340000003)
(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol
7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol
(1s,2s,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(1s,4r,4as,7r,7as,11as)-8-(1h-indol-3-yl)-9-isopropyl-4,4a,7-trimethyl-1h,2h,3h,4h,5h,6h,7h,7ah,10h,11h-cyclohexa[e]naphthalen-1-ol
(2r,3r,4s,7r,8s,11r,12r,15s)-4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol
(1s,2s,4as,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
6-(1h-indol-3-ylmethyl)-1,4a-dimethyl-5-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(1r,4as,4br,7r,8s,8ar,10as)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
2-amino-n-[(1s,2r,3r,4s,5s,6r)-4-amino-3-{[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5-dihydroxy-6-methoxycyclohexyl]-n-methylacetamide
C17H35N5O6 (405.25872100000004)
5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(1s,2s,4ar,5r,8ar)-5-(1h-indol-3-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
(2s,5s,6r,9s,11r,14r,15s)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
(1s,4r,8r)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
4,7,8,16,16-pentamethyl-22-azahexacyclo[15.6.1.0²,¹⁵.0³,¹².0⁷,¹².0²¹,²⁴]tetracosa-1(23),17(24),18,20-tetraen-11-ol
8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
(1s,4r,4as,7r,7as,8s,9r,11as)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
(1r,4s,4ar,7s,7ar,8r,9s,11ar)-8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
(1s,2r,5r,6s)-5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(1r,4ar,4br,7r,8s,8as,10ar)-8-(1h-indol-3-ylmethyl)-1,4b,7,8,10a-pentamethyl-decahydrophenanthren-2-one
1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol
n-(6-hydroxy-1,6-dimethyl-4-{2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl}-5-(methylideneamino)-octahydronaphthalen-1-yl)carboximidic acid
(3as,4s,6as,7r,8s,10ar)-7-(1h-indol-3-ylmethyl)-3a,7,8-trimethyl-1-(propan-2-ylidene)-octahydro-2h-cyclopenta[e]naphthalen-4-ol
(1s,2s,4ar,5s,8ar)-5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
n-{2-[(2s,5r)-5-[(1s,4s,4as,7r,8r,8as)-7-hydroxy-4,7-dimethyl-4,8-bis(methylideneamino)-octahydronaphthalen-1-yl]-5-methyloxolan-2-yl]propan-2-yl}carboximidic acid
5-(1h-indol-2-ylmethyl)-1,4a-dimethyl-6-methylidene-1-(4-methylpent-3-en-1-yl)-hexahydro-2h-naphthalen-2-ol
(4s,6s,8s,10s,11e,13e,15z)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
(1s,4r,4as,8r,8as)-8-(1h-indol-3-ylmethyl)-4,4a-dimethyl-7-methylidene-8a-(4-methylpent-3-en-1-yl)-hexahydro-1h-naphthalen-1-ol
2-{1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl}propan-2-ol
(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyheptadeca-4,6,9-trienimidic acid
C24H39NO4 (405.28789340000003)
5-(1h-indol-3-ylmethyl)-1,5,6-trimethyl-1-(4-methylpent-3-en-1-yl)-2,3,4,6,7,8-hexahydronaphthalen-2-ol
(1s,12s,15r,16s,17s,20s)-1,16,20-trimethyl-16-(4-methylpent-3-en-1-yl)-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-ol
n-[(1s,4s,4as,5r,6r,8as)-6-hydroxy-1,6-dimethyl-4-[(2r,5s)-2-methyl-5-[2-(methylideneamino)propan-2-yl]oxolan-2-yl]-5-(methylideneamino)-octahydronaphthalen-1-yl]carboximidic acid
2-(dimethylamino)ethyl 2-[(1r,2e,4ar,4br,7s,8ar,10as)-7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-decahydrophenanthren-2-ylidene]acetate
C24H39NO4 (405.28789340000003)
(2r,5r,6s,9r,11s,14s,15r)-2,6,10,10,14-pentamethyl-19-azahexacyclo[15.6.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0²⁰,²⁴]tetracosa-1(24),17,20,22-tetraen-9-ol
n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyheptadeca-4,6,9-trienimidic acid
C24H39NO4 (405.28789340000003)
2-[(1s,2s,5s,7s,11r,14s)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-7-yl]propan-2-ol
8-(1h-indol-3-yl)-4,4a,7-trimethyl-9-(prop-1-en-2-yl)-dodecahydrocyclohexa[e]naphthalen-1-ol
7-(1h-indol-3-ylmethyl)-1-isopropyl-3a,7,8-trimethyl-3h,4h,5h,6h,6ah,8h,9h,10h-cyclopenta[e]naphthalen-4-ol
(4s,6s,8s,10s,11e,13z,15e)-16-isocyano-4,6,8,10-tetramethoxy-11,13-dimethylheptadeca-1,11,13,15-tetraene
C24H39NO4 (405.28789340000003)
11-ethyl-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol
C24H39NO4 (405.28789340000003)